Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Soluble Mediators and Clinical Features Discern Risk of Transitioning to Classified Disease in Relatives of Systemic Lupus Erythematosus Patients.

Munroe ME, Young KA, Kamen DL, Guthridge JM, Niewold TB, Costenbader KH, Weisman MH, Ishimori ML, Wallace DJ, Gilkeson GS, Karp DR, Harley JB, Norris JM, James JA.

Arthritis Rheumatol. 2016 Nov 18. doi: 10.1002/art.40004. [Epub ahead of print]

PMID:
27863174
2.

Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.

López De Padilla CM, Crowson CS, Hein MS, Pendegraft RS, Strausbauch MA, Niewold TB, Ernste FC, Peterson E, Baechler EC, Reed AM.

J Rheumatol. 2016 Nov 1. pii: jrheum.160293. [Epub ahead of print]

PMID:
27803134
3.

Elevated procalcitonin levels in a severe lupus flare without infection.

Wallbach M, Vasko R, Hoffmann S, Niewold TB, Müller GA, Korsten P.

Lupus. 2016 Dec;25(14):1625-1626. No abstract available.

PMID:
27216419
4.

Genetics of human lupus nephritis.

Iwamoto T, Niewold TB.

Clin Immunol. 2016 Sep 28. pii: S1521-6616(16)30426-0. doi: 10.1016/j.clim.2016.09.012. [Epub ahead of print]

PMID:
27693588
5.

Manifestations of systemic lupus erythematosus in female patients with polysomy X: Possible roles of chromosome X.

Iwamoto T, Fujimoto M, Ikeda K, Saku A, Makita S, Furuta S, Niewold TB, Nakajima H.

Mod Rheumatol. 2016 Jul 12:1-3. [Epub ahead of print]

PMID:
27401488
6.

Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria.

Ungprasert P, Sagar V, Crowson CS, Amin S, Makol A, Ernste FC, Osborn TG, Moder KG, Niewold TB, Maradit-Kremers H, Ramsey-Goldman R, Chowdhary VR.

Lupus. 2016 Jun 30. pii: 0961203316657434. [Epub ahead of print]

PMID:
27365370
7.

Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Young KA, Munroe ME, Guthridge JM, Kamen DL, Niewold TB, Gilkeson GS, Weisman MH, Ishimori ML, Kelly J, Gaffney PM, Sivils KH, Lu R, Wallace DJ, Karp DR, Harley JB, James JA, Norris JM.

Ann Rheum Dis. 2016 Jun 9. pii: annrheumdis-2016-209157. doi: 10.1136/annrheumdis-2016-209157. [Epub ahead of print]

PMID:
27283331
8.

Connective tissue diseases: Targeting type I interferon in systemic lupus erythematosus.

Niewold TB.

Nat Rev Rheumatol. 2016 Jul;12(7):377-8. doi: 10.1038/nrrheum.2016.83. No abstract available.

PMID:
27225301
9.

Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.

Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, James JA.

Ann Rheum Dis. 2016 Nov;75(11):2014-2021. doi: 10.1136/annrheumdis-2015-208140.

PMID:
27088255
10.

Drugs in early clinical development for Systemic Lupus Erythematosus.

Postal M, Sinicato NA, Appenzeller S, Niewold TB.

Expert Opin Investig Drugs. 2016;25(5):573-83. doi: 10.1517/13543784.2016.1162291.

PMID:
26950689
11.

Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.

Goulielmos GN, Zervou MI, Myrthianou E, Burska A, Niewold TB, Ponchel F.

Gene. 2016 Jun 1;583(2):90-101. doi: 10.1016/j.gene.2016.02.004. Review.

PMID:
26869316
12.

Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.

Deng Y, Zhao J, Sakurai D, Sestak AL, Osadchiy V, Langefeld CD, Kaufman KM, Kelly JA, James JA, Petri MA, Bae SC, Alarcón-Riquelme ME, Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Sohn II, Lee S, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Cantor RM, Hahn BH, Grossman JM, Tsao BP.

Ann Rheum Dis. 2016 Nov;75(11):2007-2013. doi: 10.1136/annrheumdis-2015-208441.

PMID:
26783109
13.

Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.

Ghodke-Puranik Y, Puranik AS, Shintre P, Joshi K, Patwardhan B, Lamba J, Niewold TB, Chopra A.

Pharmacogenomics. 2015 Dec;16(18):2019-34. doi: 10.2217/pgs.15.145.

14.

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.

Wampler Muskardin T, Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Kern M, Curtis JR, Danila MI, Cofield SS, Shadick N, Nigrovic PA, St Clair EW, Bingham CO 3rd, Furie R, Robinson W, Genovese M, Striebich CC, O'Dell JR, Thiele GM, Moreland LW, Levesque M, Bridges SL Jr, Gregersen PK, Niewold TB.

Ann Rheum Dis. 2016 Oct;75(10):1757-62. doi: 10.1136/annrheumdis-2015-208001.

PMID:
26546586
15.

The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

López de Padilla CM, Niewold TB.

Gene. 2016 Jan 15;576(1 Pt 1):14-21. doi: 10.1016/j.gene.2015.09.058. Review.

PMID:
26410416
16.

Immunological biomarkers in dermatomyositis.

Olazagasti JM, Niewold TB, Reed AM.

Curr Rheumatol Rep. 2015 Nov;17(11):68. doi: 10.1007/s11926-015-0543-y. Review.

PMID:
26404949
17.

Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus.

Zhao J, Wu H, Langefeld CD, Kaufman KM, Kelly JA, Bae SC; Marta E. Alarcón-Riquelme for the BIOLUPUS and GENLES networks., Alarcón GS, Anaya JM, Criswell LA, Freedman BI, Kamen DL, Gilkeson GS, Jacob CO, James JA, Merrill JT, Gaffney PM, Sivils KM, Niewold TB, Petri MA, Song ST, Jeong HJ, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Boackle SA, Vilá LM, Chang DM, Song YW, Vyse TJ, Harley JB, Brown EE, Edberg JC, Kimberly RP, Hahn BH, Grossman JM, Tsao BP, La Cava A.

Clin Immunol. 2015 Dec;161(2):157-62. doi: 10.1016/j.clim.2015.09.007.

18.

Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Ghodke-Puranik Y, Niewold TB.

J Autoimmun. 2015 Nov;64:125-36. doi: 10.1016/j.jaut.2015.08.004. Review.

19.

Advances in lupus genetics.

Niewold TB.

Curr Opin Rheumatol. 2015 Sep;27(5):440-7. doi: 10.1097/BOR.0000000000000205. Review.

20.

Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations.

Sharma S, Jin Z, Rosenzweig E, Rao S, Ko K, Niewold TB.

J Autoimmun. 2015 Jun;60:51-8. doi: 10.1016/j.jaut.2015.04.002.

Items per page

Supplemental Content

Loading ...
Support Center